Key result
A 16-year-old male experienced a rare, silent, and late embolization of an atrial septal defect occluder device into the right pulmonary artery three months after implantation.
Case Report (n=1)
Highlights a rare complication of silent and late embolization of an ASD occluder device into the pulmonary artery three months post-implantation.
Alerts clinicians to rare silent complications after percutaneous ASD closure; leaves open true incidence and mechanisms.
Percutaneous device closure of atrial septal defect (ASD) is an alternative treatment to surgery. The main advantages of the percutaneous approach include avoidance of surgery, short procedure time and hospital length, in addition to comparable rates of complications. However, percutaneous device closure is associated with infrequent early and late complications including device embolization, air embolism, cardiac tamponade and thrombotic complications. We report a rare complication of silent and late device embolization of the ASD occluder device into the right pulmonary artery, three months after implantation.
No takes yet. Share an insight, caveat, or question.
Şahin et al. (2012) conducted a case report in Atrial septal defect (n=1). Percutaneous device closure with ASD septal occluder was evaluated on Device embolization. A 16-year-old male experienced a rare, silent, and late embolization of an atrial septal defect occluder device into the right pulmonary artery three months after implantation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: